BNT162b2 Vaccine Booster and Mortality Due to #Covid-19 | NEJM
▻https://www.nejm.org/doi/full/10.1056/NEJMoa2115624
Personnes de plus de 50 ans
CONCLUSIONS
Participants who received a booster at least 5 months after a second dose of BNT162b2 had 90% lower mortality due to Covid-19 than participants who did not receive a booster.